Page last updated: 2024-09-05

phosphatidylcholines and Aspergillosis

phosphatidylcholines has been researched along with Aspergillosis in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (22.86)	18.2507
2000's	27 (77.14)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunson, ME; Duchini, A; McHutchison, JG; Pockros, PJ; Redfield, DC	1
Kontoyiannis, DP; Mantadakis, E; Samonis, G	1
Butani, L; Jain, A	1
Barcena, R; Candela, A; de Vicente, E; Fortún, J; García, M; Honrubia, A; Martín-Davila, P; Moreno, S; Nuño, J; Pintado, V; Uriarte, M	1
Segal, E; Sionov, E	2
Sims-McCallum, RP	1
Bartlett, K; Batty, DS; Choo, E; Marra, F; Risovic, V; Sivak, O; Wasan, KM	1
Perfect, JR	1
Chandrasekar, PH; Ito, JI	1
Clemons, KV; Fernandez, B; Imai, J; Singh, G; Stevens, DA	1
Chandrasekar, PH; Hooshmand-Rad, R; Ito, JI	1
Bahna, P; Hachem, R; Hanna, H; Raad, I; Stephens, LC	1
Chandrasekar, P	1
Kleinberg, M	1
Cornila, C; Fohrer, C; Fornecker, L; Herbrecht, R; Marinescu, C; Nivoix, Y	1
Adler-Moore, JP; Jensen, GM; Olson, JA; Proffitt, RT; Schwartz, J	1
Clemons, KV; Martinez, M; Parmar, R; Stevens, DA	1
Edwards, JE; Fu, Y; Ibrahim, AS; Rieg, G; Schwartz, J; Sheppard, DC; Spellberg, B	1
Bartlett, K; Risovic, V; Rosland, M; Sivak, O; Wasan, KM	1
Cappelli, B; Castagnola, E; Cuzzubbo, D; Faraci, M; Lanino, E; Moresco, L; Moroni, C	1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA	1
Afif, C; Boktour, MR; Hachem, RY; Hanna, HA; Husni, RN; Kontoyiannis, DP; Raad, II; Torres, HA	1
Armstrong, D; Bernard, EM; Cicogna, CE; Ishimura, T; Sun, M; Tong, WP; White, MH	1
Adkins, D; Brown, R; DiPersio, J; Goodnough, L; Khoury, H; Miller, G	1
Guanci, R; Lilley, LL	1
Boyle, JA; Luke, RG	1
Anaissie, EJ; Bow, E; DiNubile, MJ; Hiemenz, JW; Horwith, G; Lee, L; Lister, J; Perfect, JR; Reboli, A; Seibel, NL; Silber, JL; Walsh, TJ	1
Johnson, JR; Kangas, PJ; West, M	1
Hastings, JG; Mutimer, DJ; Singhal, S	1
Arndt, C; Chanock, SJ; Dinubile, MJ; Harris, RE; Hiemenz, J; Reboli, A; Seibel, NL; Walsh, TJ	1
Ali, LI; Carter, TH; Roy, V; Selby, GB	1
Lin, SJ; Schranz, J; Teutsch, SM	1
Andrès, E; Auvrignon, A; Eyer, D; Guillemain, R; Herbrecht, R; Letscher-Bru, V; Leverger, G; Pailler, C; Schaison, G; Suc, A	1
Caillot, D; Kara-Slimane, F; Mannone, L	1

Reviews

7 review(s) available for phosphatidylcholines and Aspergillosis

Article	Year
Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach. Southern medical journal, 2002, Volume: 95, Issue:8 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Combinations; Female; Humans; Inguinal Canal; Itraconazole; Liver Transplantation; Lung; Lung Diseases, Fungal; Lymphatic Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Survival Rate	2002
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. The Journal of hospital infection, 2003, Volume: 53, Issue:4 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles	2003
Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004
What is the current and future status of conventional amphotericin B? International journal of antimicrobial agents, 2006, Volume: 27 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Colloids; Deoxycholic Acid; Drug Combinations; Humans; Liposomes; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome	2006
Antifungal combination treatment: a future perspective. International journal of antimicrobial agents, 2006, Volume: 27 Suppl 1 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Echinocandins; Forecasting; Humans; In Vitro Techniques; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols	2006
Aspergillosis case-fatality rate: systematic review of the literature. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Feb-01, Volume: 32, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Case-Control Studies; Central Nervous System Fungal Infections; Child; Child, Preschool; Clinical Trials as Topic; Cohort Studies; Drug Combinations; Female; Humans; Male; MEDLINE; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Prognosis	2001
[Invasive aspergillosis]. La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Drug Combinations; Humans; Immunosuppression Therapy; Itraconazole; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Prognosis; Radiography, Thoracic; Risk Factors; Tomography, X-Ray Computed	2001

Trials

4 trial(s) available for phosphatidylcholines and Aspergillosis

Article	Year
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia, 2008, Volume: 22, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2008
Renal effects of amphotericin B lipid complex. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Drug Combinations; Female; Humans; Kidney; Male; Meningitis, Cryptococcal; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols	1998
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Cryptococcosis; Drug Combinations; Female; Humans; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols	1998
Amphotericin B lipid complex in pediatric patients with invasive fungal infections. The Pediatric infectious disease journal, 1999, Volume: 18, Issue:8 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis	1999

Other Studies

24 other study(ies) available for phosphatidylcholines and Aspergillosis

Article	Year
Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Calcium Carbonate; Candidiasis; Cellulitis; Child; Drug Carriers; Female; Headache; Humans; Hyperparathyroidism, Secondary; Immunocompromised Host; Itraconazole; Liposomes; Mucormycosis; Orbital Diseases; Parathyroid Hormone; Phosphates; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Seizures; Sinusitis; Vitamin D	2003
Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Combinations; Female; Humans; Liver Transplantation; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors	2003
Polyene and cytokine treatment of experimental aspergillosis. FEMS immunology and medical microbiology, 2003, Dec-05, Volume: 39, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Drug Combinations; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Immunocompromised Host; Immunosuppressive Agents; Kidney; Lung; Mice; Mice, Inbred ICR; Nystatin; Phosphatidylcholines; Phosphatidylglycerols; Survival Analysis	2003
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
Treatment of murine systemic aspergillosis with polyene-intralipid admixtures. Medical mycology, 2004, Volume: 42, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Fat Emulsions, Intravenous; Female; Immunocompromised Host; Immunosuppressive Agents; Mice; Mice, Inbred ICR; Nystatin; Phosphatidylcholines; Phosphatidylglycerols; Polyenes	2004
Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis. Journal of pharmaceutical sciences, 2004, Volume: 93, Issue:6 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley	2004
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40 Suppl 6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Combinations; Female; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome	2005
Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols	2005
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Bone marrow transplantation, 2005, Volume: 36, Issue:10 Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Child; Child, Preschool; Databases, Factual; Drug Combinations; Drug Evaluation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Transplantation, Homologous; Treatment Outcome	2005
EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcium; Colony Count, Microbial; Confidence Intervals; Creatinine; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edetic Acid; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Survival Analysis; Time Factors	2006
The experience is CLEAR. International journal of antimicrobial agents, 2006, Volume: 27 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cryptococcosis; Databases, Factual; Drug Combinations; Humans; In Vitro Techniques; Multicenter Studies as Topic; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome; Zygomycosis	2006
Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Administration, Inhalation; Aerosols; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blood Urea Nitrogen; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Kidney Tubules; Liposomes; Lung Diseases, Fungal; Mice; Mice, Inbred DBA; Phosphatidylcholines; Phosphatidylglycerols; Survival Analysis; Time Factors	2006
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole	2006
Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Drug Combinations; Injections, Intravenous; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Time Factors	2006
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus. Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Echinocandins; Galactose; Injections, Intravenous; Lipopeptides; Male; Mannans; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Tissue Distribution	2007
Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3 Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Lung Diseases, Fungal; Mitochondrial Diseases; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Syndrome; Transplantation, Homologous	2007
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer, 2008, Mar-15, Volume: 112, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Combinations; Female; Hematologic Neoplasms; Humans; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome	2008
Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Aerosols; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Combinations; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley	1997
Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone marrow transplantation, 1997, Volume: 20, Issue:2 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Encephalitis; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphatidylcholines; Phosphatidylglycerols; Prognosis	1997
Communication averts an overdose. The American journal of nursing, 1998, Volume: 98, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Communication; Drug Combinations; Drug Overdose; Drug Prescriptions; Humans; Male; Medication Errors; Middle Aged; Personnel, Hospital; Phosphatidylcholines; Phosphatidylglycerols	1998
Serious adverse event after unrecognized substitution of one amphotericin B lipid preparation for another. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:5 Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Carriers; Drug Combinations; Drug Compounding; Humans; Kidney Transplantation; Male; Phosphatidylcholines; Phosphatidylglycerols	1998
Safety of high-dose amphotericin B lipid complex. Bone marrow transplantation, 1999, Volume: 24, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Combinations; Humans; Phosphatidylcholines; Phosphatidylglycerols	1999
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease. The Journal of infection, 2000, Volume: 41, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lymphoma, Follicular; Male; Mucormycosis; Opportunistic Infections; Pancytopenia; Phosphatidylcholines; Phosphatidylglycerols	2000
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Leukemia; Lung Transplantation; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies	2001